Nectar Lifesciences Ltd. Financial Overview
Nectar Lifesciences Ltd.'s market cap is currently ₹4.73B. The company's EPS TTM is ₹-7.848; its P/E ratio is -1.32; Nectar Lifesciences Ltd. is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
